JEFMEDIUM SIGNALFINANCIAL10-Q

Jefferies shows mixed quarterly performance with substantially higher operating income offset by a sharp decline in net income and elevated working capital requirements.

The meaningful expansion in operating income suggests improved core business performance, but the substantial drop in net income indicates significant non-operating headwinds or one-time charges that warrant closer examination. The notable increase in both current assets and liabilities reflects expanded business activity but requires monitoring for liquidity management effectiveness.

Comparing 2026-04-07 vs 2025-10-09View on EDGAR →
FINANCIAL ANALYSIS

Jefferies delivered substantially improved operating performance with operating income growing meaningfully quarter-over-quarter, though this was more than offset by factors that drove net income substantially lower. The balance sheet shows expanded business activity with current assets and liabilities both rising notably, while cash levels declined moderately. Operating cash flow remained negative but improved meaningfully, suggesting ongoing working capital intensity typical of the investment banking business.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+87.9%
$43.0M$80.8M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
-70.5%
$195.5M$57.7M

Net income declined 70.5% — review whether driven by operations, interest costs, or non-recurring items.

Current Assets
Balance Sheet
+66.4%
$1.3B$2.1B

Current assets grew 66.4% — improving short-term liquidity or inventory/receivables build.

Current Liabilities
Balance Sheet
+64%
$794.4M$1.3B

Current liabilities surged 64% — significant near-term obligations; verify ability to meet short-term debt.

Operating Cash Flow
Cash Flow
+34.8%
-$2.7B-$1.7B

Operating cash flow surged 34.8% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+30.8%
$49.6M$64.9M

Capital expenditure jumped 30.8% — major investment cycle underway; assess returns on deployment.

Cash & Equivalents
Balance Sheet
-14.8%
$14.0B$12.0B

Cash decreased 14.8% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-04-07
PRIOR — 2025-10-09
ADDED
Index to Quarterly Report on Form 10-Q February 28, 2026 PART I.
Consolidated Statements of Financial Condition (Unaudited) February 28, November 30, $ in thousands, except share and per share amounts 2026 2025 Assets Cash and cash equivalents ...............................................................................................................................................................
$ 11,963,165 $ 14,043,889 Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations .................................................................................................................................................................................
1,752,549 917,697 Financial instruments owned, at fair value (includes securities pledged of $ 18,129,409 and $ 17,419,373 ) .......................
28,079,458 27,722,739 Investments in and loans to related parties ...................................................................................................................................
+7 more — sign up free →
REMOVED
Index to Quarterly Report on Form 10-Q August 31, 2025 PART I.
Consolidated Statements of Financial Condition (Unaudited) $ in thousands, except share and per share amounts August 31, 2025 November 30, 2024 Assets Cash and cash equivalents ...............................................................................................................................................................
$ 11,458,472 $ 12,153,414 Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations (includes $ 120,414 of securities at fair value at November 30, 2024) .........................................................
1,111,620 1,132,612 Financial instruments owned, at fair value (includes securities pledged of $ 18,135,984 and $ 18,441,751 ) .......................
26,117,064 24,138,274 Investments in and loans to related parties ...................................................................................................................................
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →